Breo Ellipta 25 mcg

BREO ELLIPTA 25 MCG is an inhalation powder containing vilanterol trifenate. It is used for managing respiratory conditions like asthma and COPD. This medication helps improve breathing and reduce symptoms.

BREO ELLIPTA 25 MCG is primarily used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). Vilanterol, the active ingredient, works as a long-acting beta-agonist to help open the airways, making it easier to breathe. This medication is often prescribed to manage symptoms such as wheezing, shortness of breath, and coughing associated with these conditions.

Common effects of BREO ELLIPTA 25 MCG may include mild headache, throat irritation, and a dry mouth. Some users might experience tremors or an increased heart rate. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare professional.

BREO ELLIPTA 25 MCG should be used as directed by a healthcare provider. It is important to follow the prescribed dosage and administration instructions. Patients with certain medical conditions, such as heart disease or high blood pressure, should use this medication with caution. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

BREO ELLIPTA 25 MCG may interact with other medications, including beta-blockers, which can reduce its effectiveness. It is also important to avoid using this medication with other long-acting beta-agonists to prevent overstimulation of the airways. Always consult a healthcare provider before combining BREO ELLIPTA with other medications.